USPTO trademark

IBES

Awaiting publicationUSPTOWord markClass 5Class 40

"IBES" is a word mark owned by Singulera Therapeutics Inc., filed at the USPTO on February 26, 2026. It is waiting to be published and covers classes 5 and 40.

Get this data via the API
Official USPTO record
IBES trademark as filed
As filed with the USPTO
Status
Awaiting publication
Since October 12, 2026
Filed
February 26, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99672754
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns IBES

The owner and representative on file with the office.

Owner

Singulera Therapeutics Inc.

Chicago, United States

Representative

Joe McKinney Muncy

Muncy, Geissler, Olds & Lowe, P.C.

Goods and services

What the mark covers

The products and services IBES is filed for, grouped by Nice class.

  • Syringes filled with pharmaceuticals for the treatment of osteoarthritis and other degenerative joint diseases; Syringes filled with pharmaceuticals for chronic wound healing, including non-healing ulcers; Syringes filled with immune-modulating pharmaceuticals for autoimmune diseases and transplant rejection prevention; Syringes filled with pharmaceuticals for cardiovascular diseases, including acute myocardial infarction and ischemic conditions; Syringes filled with regenerative pharmaceuticals for skin and tissue repair; Organotherapy preparations; Biological preparations for use in cell cultures for medical purposes; Pharmaceutical and biological preparations for diagnostic, medical, therapeutic and prophylactic use, namely for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; Pharmaceutical preparations for use in treatment, amelioration and prophylaxis of diseases, disorders and suppression of the immune system; Pharmaceutical preparations for cell therapy for medical purposes; Pharmaceutical preparations for gene therapy for medical purposes; Pharmaceutical preparations for genetically modifying human and animal cells for diagnostic and medical purposes; Pharmaceutical preparations for therapies to modulate the immune system; Pharmaceutical preparations for therapeutic delivery of nucleic acids; Medical pharmaceutical preparations containing viral vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; Medical preparations containing nucleic acid vectors for therapeutic and prophylactic purposes for the treatment of genetic, autoimmune and inflammatory diseases, disorders and deficiencies, and for preventing organ transplant rejection; Stem cells for medical purposes; Biological reagent for medical purposes; Opotherapy preparations

  • Custom manufacturing of pharmaceuticals, excluding services relating to the development or establishment of general bioprocesses or biomanufacturing facilities for the life sciences industry; Custom biomanufacturing of pharmaceuticals, excluding services relating to the development or establishment of general bioprocesses or biomanufacturing facilities for the life sciences industry

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Approved for pub - principal register
  2. Teas/email correspondence entered
  3. Correspondence received in law office
  4. Teas response to office action received
  5. Notification of non-final action e-mailed
  6. Non-final action e-mailed
  7. Non-final action written
  8. Assigned to examiner
  9. New application office supplied data entered
  10. Application filing receipt mailed

1 earlier step on the official record.

FAQ

About IBES

Who owns the trademark "IBES"?

The USPTO trademark "IBES" (application 99672754) is owned by Singulera Therapeutics Inc.

What is the status of "IBES"?

Its status at the USPTO is: awaiting publication.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull IBES and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2baf-3a90-700e-8af3-19f8ed2ac09e
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2baf-3a90-700e-8af3-19f8ed2ac09e",
  "object": "trademark",
  "mark_text": "IBES",
  "status": {
    "primary": "pending",
    "stage": "pending_publication"
  },
  "office_code": "US",
  "application_number": "99672754",
  "filing_date": "2026-02-26",
  "nice_classes": [
    5,
    40
  ],
  "owners": [
    {
      "name": "Singulera Therapeutics Inc.",
      "entity_id": null
    }
  ]
}